收费全文 | 3082940篇 |
免费 | 220432篇 |
国内免费 | 4433篇 |
耳鼻咽喉 | 43210篇 |
儿科学 | 100177篇 |
妇产科学 | 83111篇 |
基础医学 | 450201篇 |
口腔科学 | 85708篇 |
临床医学 | 278330篇 |
内科学 | 590939篇 |
皮肤病学 | 68650篇 |
神经病学 | 240658篇 |
特种医学 | 117278篇 |
外国民族医学 | 676篇 |
外科学 | 464301篇 |
综合类 | 63116篇 |
现状与发展 | 13篇 |
一般理论 | 1044篇 |
预防医学 | 235464篇 |
眼科学 | 72177篇 |
药学 | 235342篇 |
18篇 | |
中国医学 | 6537篇 |
肿瘤学 | 170855篇 |
2019年 | 24403篇 |
2018年 | 34010篇 |
2017年 | 25907篇 |
2016年 | 29162篇 |
2015年 | 32766篇 |
2014年 | 45963篇 |
2013年 | 68839篇 |
2012年 | 94531篇 |
2011年 | 100617篇 |
2010年 | 59784篇 |
2009年 | 56257篇 |
2008年 | 94247篇 |
2007年 | 100643篇 |
2006年 | 101562篇 |
2005年 | 98249篇 |
2004年 | 94096篇 |
2003年 | 90722篇 |
2002年 | 87806篇 |
2001年 | 145893篇 |
2000年 | 150060篇 |
1999年 | 125914篇 |
1998年 | 35429篇 |
1997年 | 31139篇 |
1996年 | 31450篇 |
1995年 | 29574篇 |
1994年 | 27209篇 |
1993年 | 25662篇 |
1992年 | 96969篇 |
1991年 | 94298篇 |
1990年 | 92435篇 |
1989年 | 88937篇 |
1988年 | 81529篇 |
1987年 | 79934篇 |
1986年 | 75040篇 |
1985年 | 71535篇 |
1984年 | 52936篇 |
1983年 | 44980篇 |
1982年 | 26247篇 |
1979年 | 48439篇 |
1978年 | 34069篇 |
1977年 | 28972篇 |
1976年 | 26993篇 |
1975年 | 29530篇 |
1974年 | 35028篇 |
1973年 | 33518篇 |
1972年 | 31691篇 |
1971年 | 29945篇 |
1970年 | 27596篇 |
1969年 | 26414篇 |
1968年 | 23979篇 |
Purpose
Endovascular treatment with mechanical thrombectomy devices demonstrated high recanalization rates but functional outcome did not correlate with high rates of recanalization obtained. Patient selection prior to the endovascular treatment is very important in the final outcome of the patient. The primary aim of our study was to evaluate the prognostic value of posterior circulation Alberta Stroke Program Early CT Score (pc-ASPECTS) and Pons-Midbrain Index (PMI) scores in patients with Basilar Artery Occlusion (BAO) treated with successful angiographic recanalization after mechanical thrombectomy.Methods
Retrospective single-center study including 18 patients between 2008 and 2013 who had acute basilar artery occlusion managed with endovascular treatment within 24 hours from symptoms onset and with successful angiographic recanalization. The patients were initially classified into two groups according to clinical outcome and mortality at 90 days. For analysis we also divided patients into groups based on pc-ASPECTS (≥8vs.< 8) and PMI (≥3vs.< 3) on non-contrast CT (NCCT) and CT Angiography Source Images (CTASI). Imaging data were correlated to clinical outcome and mortality rate.Results
CTASI pc-ASPECTS, dichotomized at < 8 versus≥8, was associated with a favorable outcome (RR: 2.6; 95% CI: 1.3-5.2) and a reduced risk of death (RR: 6.5: 95% CI: 7.8-23.3). All patients that survived and were functionally independent had pc-ASPECTS score≥8. None of the 5 patients with CTASI pc-ASPECTS score less than 8 survived.Conclusion
PC-ASPECTS on CTASI is helpful for predicting functional outcome after BAO recanalization with endovascular treatment. These results should be validated in a randomized controlled trial in order to decide whether or not to treat a patient with BAO. 相似文献Areas covered: This review covers the mechanism of action, safety and efficacy of sacituzumab govitecan in patients with previously treated, metastatic TNBC. Additionally, efficacy data in other epithelial malignancies is included based on a PubMed search for ‘sacituzumab govitecan’ and ‘clinical trial’.
Expert opinion: Sacituzumab govitecan has promising anti-cancer activity in patients with metastatic TNBC previously treated with at least two prior lines of systemic therapy based on a single arm Phase I/II clinical trial. A confirmatory Phase III randomized clinical trial is ongoing. Sacituzumab govitecan has a manageable side effect profile, with the most common adverse events being nausea, neutropenia, and diarrhea. The activity of sacituzumab govitecan likely extends beyond TNBC with promising early efficacy data in many other epithelial cancers, including hormone receptor-positive breast cancer. 相似文献